HK1152898A1 - 用於治療乾眼症的β-轉角模擬肽環狀化合物 - Google Patents

用於治療乾眼症的β-轉角模擬肽環狀化合物

Info

Publication number
HK1152898A1
HK1152898A1 HK11107167.9A HK11107167A HK1152898A1 HK 1152898 A1 HK1152898 A1 HK 1152898A1 HK 11107167 A HK11107167 A HK 11107167A HK 1152898 A1 HK1152898 A1 HK 1152898A1
Authority
HK
Hong Kong
Prior art keywords
dry eye
cyclic compounds
treating dry
beta turn
peptidomimetic cyclic
Prior art date
Application number
HK11107167.9A
Other languages
English (en)
Inventor
Garth Cumberlidge
Karen Meerovitch
Teresa Lama
Uri H Saragovi
Original Assignee
Mimetogen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mimetogen Pharmaceuticals Inc filed Critical Mimetogen Pharmaceuticals Inc
Publication of HK1152898A1 publication Critical patent/HK1152898A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/123—Tripeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK11107167.9A 2008-04-04 2011-07-11 用於治療乾眼症的β-轉角模擬肽環狀化合物 HK1152898A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12303608P 2008-04-04 2008-04-04
US20887309P 2009-02-27 2009-02-27
PCT/US2009/002121 WO2009123761A1 (en) 2008-04-04 2009-04-03 Beta-turn peptidomimetic cyclic compounds for treating dry eye

Publications (1)

Publication Number Publication Date
HK1152898A1 true HK1152898A1 (zh) 2012-03-16

Family

ID=40897413

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11107167.9A HK1152898A1 (zh) 2008-04-04 2011-07-11 用於治療乾眼症的β-轉角模擬肽環狀化合物

Country Status (10)

Country Link
US (4) US8293713B2 (zh)
EP (1) EP2271337B1 (zh)
JP (2) JP5480242B2 (zh)
KR (1) KR101565185B1 (zh)
CN (1) CN102046166B (zh)
AU (1) AU2009232352B2 (zh)
CA (1) CA2720141C (zh)
ES (1) ES2521515T3 (zh)
HK (1) HK1152898A1 (zh)
WO (1) WO2009123761A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102046166B (zh) 2008-04-04 2012-10-17 米梅托根药物公司 用于治疗干眼症的β-转角模拟肽环状化合物
CN104619717B (zh) * 2012-06-22 2019-04-02 米梅奥亨制药公司 β-转角模拟肽环状化合物的合成
KR20150004652A (ko) 2013-07-03 2015-01-13 삼성디스플레이 주식회사 표시 패널, 이를 포함하는 표시 장치 및 이를 이용하는 영상 표시 방법
JP6267003B2 (ja) * 2014-02-27 2018-01-24 参天製薬株式会社 ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤
CN113230021A (zh) 2015-01-12 2021-08-10 科达莱昂治疗公司 微滴递送设备和方法
EP3253433A4 (en) 2015-04-10 2018-08-22 Kedalion Therapeutics, Inc. Piezoelectric dispenser with replaceable ampoule
CA2991661A1 (en) 2015-07-09 2017-01-12 Mimetogen Pharmaceuticals, Inc. Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts
KR101718733B1 (ko) 2015-08-21 2017-03-22 국제약품 주식회사 레바미피드의 가용화 방법 및 이에 의해 제조된 안구건조증 치료용 액제
JP2019507193A (ja) 2016-03-04 2019-03-14 ジェームズ・エム・ライナーソン 細菌のバイオフィルム形成を阻止又は妨害することによって眼障害を治療する方法
CA3039106A1 (en) 2017-01-20 2018-07-26 Kedalion Therapeutics, Inc. Piezoelectric fluid dispenser
WO2019113483A1 (en) 2017-12-08 2019-06-13 Kedalion Therapeutics, Inc. Fluid delivery alignment system
CN110092799B (zh) * 2018-01-29 2021-11-12 广州丹康医药生物有限公司 一种环状化合物、其制备方法和应用
US12097145B2 (en) 2019-03-06 2024-09-24 Bausch + Lomb Ireland Limited Vented multi-dose ocular fluid delivery system
US11679028B2 (en) 2019-03-06 2023-06-20 Novartis Ag Multi-dose ocular fluid delivery system
US11925577B2 (en) 2020-04-17 2024-03-12 Bausch + Lomb Ireland Limted Hydrodynamically actuated preservative free dispensing system
US11938057B2 (en) 2020-04-17 2024-03-26 Bausch + Lomb Ireland Limited Hydrodynamically actuated preservative free dispensing system
WO2021212038A1 (en) 2020-04-17 2021-10-21 Kedalion Therapeutics, Inc. Hydrodynamically actuated preservative free dispensing system having a collapsible liquid reservoir
JP2024520670A (ja) * 2021-06-02 2024-05-24 ザ テキサス エーアンドエム ユニヴァーシティ システム Ｔｒｋ受容体の選択的小分子アゴニスト及び部分アゴニスト
KR20240108412A (ko) * 2021-10-20 2024-07-09 스텔스 바이오테라퓨틱스 인코포레이티드 안과 병태를 치료하거나, 예방하거나, 억제하거나, 경감하거나 발병을 지연시키기 위한 방법 및 펩타이드 모방체를 포함하는 조성물
WO2023069255A1 (en) * 2021-10-20 2023-04-27 Stealth Biotherapeutics Inc. Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917217D0 (en) * 1989-07-27 1989-09-13 Smith & Nephew Ophthalmic compositions
US5545617A (en) 1993-11-12 1996-08-13 The Schepens Eye Research Institute, Inc. Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
KR20010033484A (ko) * 1997-12-22 2001-04-25 휴먼 게놈 사이언시즈, 인크. 각질세포 성장 인자-2 제제
JP2001064198A (ja) 1999-08-24 2001-03-13 Teika Seiyaku Kk 角膜疾患治療剤
ATE340571T1 (de) 2000-01-18 2006-10-15 Univ Mcgill Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen
ATE423135T1 (de) 2005-06-13 2009-03-15 Primm Srl Heterodimere peptide mit ngf aktivität und deren verwendung zur behandlung von neurodegenerativen krankheiten
EP1921087A1 (en) 2006-11-10 2008-05-14 Primm S.R.L. Process for the preparation of cyclic peptides
CA2671613C (en) 2006-12-05 2018-07-03 The Royal Institution For The Advancement Of Learning/Mcgill University Methods of use of trk receptor modulators
CN102046166B (zh) 2008-04-04 2012-10-17 米梅托根药物公司 用于治疗干眼症的β-转角模拟肽环状化合物
AU2010217889B2 (en) * 2009-02-27 2014-12-18 Mimetogen Pharmaceuticals Inc. Peptidomimetic cyclic compounds for treating retinitis pigmentosa
CN104619717B (zh) * 2012-06-22 2019-04-02 米梅奥亨制药公司 β-转角模拟肽环状化合物的合成

Also Published As

Publication number Publication date
CN102046166B (zh) 2012-10-17
EP2271337B1 (en) 2014-09-03
EP2271337A1 (en) 2011-01-12
CA2720141C (en) 2014-01-28
ES2521515T3 (es) 2014-11-12
CN102046166A (zh) 2011-05-04
AU2009232352B2 (en) 2013-09-05
US20120322747A1 (en) 2012-12-20
JP2014080447A (ja) 2014-05-08
JP5870348B2 (ja) 2016-02-24
US9707267B2 (en) 2017-07-18
KR20110010712A (ko) 2011-02-07
KR101565185B1 (ko) 2015-11-02
US20160082072A1 (en) 2016-03-24
US9156882B2 (en) 2015-10-13
CA2720141A1 (en) 2009-10-08
US8748391B2 (en) 2014-06-10
US8293713B2 (en) 2012-10-23
JP5480242B2 (ja) 2014-04-23
AU2009232352A1 (en) 2009-10-08
JP2011516477A (ja) 2011-05-26
WO2009123761A1 (en) 2009-10-08
US20140274910A1 (en) 2014-09-18
US20110105410A1 (en) 2011-05-05

Similar Documents

Publication Publication Date Title
HK1152898A1 (zh) 用於治療乾眼症的β-轉角模擬肽環狀化合物
HK1152470A1 (zh) 治療β-澱粉樣變性病的多肽
PL2128324T3 (pl) Traktowanie tekstyliów
IL207892A0 (en) Agent for treating disease
IL225924A (en) Dlbcl treatment
HK1151533A1 (zh) 種治療疾病的試劑
ZA201007215B (en) Agent for treating disease
IL209894A0 (en) Compounds for treating amyloidoses
IL211774A (en) Animal Care Device
IL200390A0 (en) Banana treatments
HK1177118A1 (zh) 用於治療虱病的梳子
ZA201204845B (en) Agents for treating disease
IL212212A0 (en) Compound useful for treating cellulite
EP2327974A4 (en) TISSUE TREATMENT DEVICE
HK1154797A1 (zh) 治療疾病的成分
ZA201009226B (en) Nifurtimox for treating disease caused by trichomonadida
EP2410846A4 (en) GLYCOLIPIDES AS TREATMENT OF DISEASES
IL209947A (en) Compounds for the treatment of corneal inflammation
IL213287A0 (en) Treatment for glomerulonephritis
GB2458895B (en) Combing device
SI2341937T1 (sl) Sestavek za zdravljenje bolezni
EP2320728A4 (en) TAXANE COMPOUNDS FOR TREATING OCULAR DISEASE
GB0813824D0 (en) Textile treatment
GB0818713D0 (en) Substances useful for treating diseases
ZA201104003B (en) Drug for treating infections

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: ADDITION OF INVENTOR: SARAGOVI, URI, H. - 391/394